Altimmune, Inc.ALTNASDAQ
Loading
Year-over-year total asset growth rate
5Y CAGR
+40.2%/yr
Long-term compound
Percentile
P85
Within normal range
vs 5Y Ago
5.4x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 28.15% |
| Q3 2025 | 14.76% |
| Q2 2025 | 21.04% |
| Q1 2025 | 12.89% |
| Q4 2024 | -5.79% |
| Q3 2024 | -14.70% |
| Q2 2024 | -7.97% |
| Q1 2024 | -10.58% |
| Q4 2023 | 26.46% |
| Q3 2023 | -9.13% |
| Q2 2023 | -2.01% |
| Q1 2023 | -9.59% |
| Q4 2022 | -8.15% |
| Q3 2022 | 7.32% |
| Q2 2022 | 2.06% |
| Q1 2022 | -6.03% |
| Q4 2021 | -7.62% |
| Q3 2021 | -7.91% |
| Q2 2021 | -2.65% |
| Q1 2021 | 7.81% |
| Q4 2020 | 5.20% |
| Q3 2020 | 127.22% |
| Q2 2020 | 89.08% |
| Q1 2020 | 0.32% |
| Q4 2019 | -4.13% |
| Q3 2019 | -9.02% |
| Q2 2019 | -5.20% |
| Q1 2019 | 19.40% |
| Q4 2018 | 3.57% |
| Q3 2018 | 1.46% |
| Q2 2018 | -14.40% |
| Q1 2018 | -3.43% |
| Q4 2017 | -15.22% |
| Q3 2017 | -18.16% |
| Q2 2017 | 338.25% |
| Q1 2017 | -90.78% |
| Q4 2016 | 59.91% |
| Q3 2016 | 403.16% |
| Q2 2016 | 49.09% |
| Q1 2016 | -5.68% |